JP2015512403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512403A5
JP2015512403A5 JP2015503344A JP2015503344A JP2015512403A5 JP 2015512403 A5 JP2015512403 A5 JP 2015512403A5 JP 2015503344 A JP2015503344 A JP 2015503344A JP 2015503344 A JP2015503344 A JP 2015503344A JP 2015512403 A5 JP2015512403 A5 JP 2015512403A5
Authority
JP
Japan
Prior art keywords
composition
composition according
treatment
synthetic cationic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015503344A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512403A (ja
JP6224069B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/032535 external-priority patent/WO2013142374A1/en
Publication of JP2015512403A publication Critical patent/JP2015512403A/ja
Publication of JP2015512403A5 publication Critical patent/JP2015512403A5/ja
Application granted granted Critical
Publication of JP6224069B2 publication Critical patent/JP6224069B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015503344A 2012-03-23 2013-03-15 組織適合特性を有する抗菌剤の組成物および使用 Active JP6224069B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261615150P 2012-03-23 2012-03-23
US61/615,150 2012-03-23
US201261625757P 2012-04-18 2012-04-18
US201261625760P 2012-04-18 2012-04-18
US61/625,757 2012-04-18
US61/625,760 2012-04-18
US201261716242P 2012-10-19 2012-10-19
US61/716,242 2012-10-19
PCT/US2013/032535 WO2013142374A1 (en) 2012-03-23 2013-03-15 Compositions and uses of antimicrobial materials with tissue-compatible properties

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017194019A Division JP2018020175A (ja) 2012-03-23 2017-10-04 組織適合特性を有する抗菌剤の組成物および使用

Publications (3)

Publication Number Publication Date
JP2015512403A JP2015512403A (ja) 2015-04-27
JP2015512403A5 true JP2015512403A5 (enExample) 2016-02-04
JP6224069B2 JP6224069B2 (ja) 2017-11-01

Family

ID=49223273

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015503344A Active JP6224069B2 (ja) 2012-03-23 2013-03-15 組織適合特性を有する抗菌剤の組成物および使用
JP2017194019A Pending JP2018020175A (ja) 2012-03-23 2017-10-04 組織適合特性を有する抗菌剤の組成物および使用
JP2019166236A Active JP7255787B2 (ja) 2012-03-23 2019-09-12 組織適合特性を有する抗菌剤の組成物および使用
JP2020184556A Pending JP2021020964A (ja) 2012-03-23 2020-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2022176900A Pending JP2023011850A (ja) 2012-03-23 2022-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2025019121A Pending JP2025065375A (ja) 2012-03-23 2025-02-07 組織適合特性を有する抗菌剤の組成物および使用

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017194019A Pending JP2018020175A (ja) 2012-03-23 2017-10-04 組織適合特性を有する抗菌剤の組成物および使用
JP2019166236A Active JP7255787B2 (ja) 2012-03-23 2019-09-12 組織適合特性を有する抗菌剤の組成物および使用
JP2020184556A Pending JP2021020964A (ja) 2012-03-23 2020-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2022176900A Pending JP2023011850A (ja) 2012-03-23 2022-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2025019121A Pending JP2025065375A (ja) 2012-03-23 2025-02-07 組織適合特性を有する抗菌剤の組成物および使用

Country Status (16)

Country Link
US (4) US9446090B2 (enExample)
EP (2) EP4516101A3 (enExample)
JP (6) JP6224069B2 (enExample)
KR (2) KR102266659B1 (enExample)
CN (1) CN104582688A (enExample)
AU (2) AU2013235336B2 (enExample)
BR (1) BR112014023068B1 (enExample)
CA (1) CA2867903C (enExample)
ES (1) ES2991989T3 (enExample)
HU (1) HUE069626T2 (enExample)
IN (1) IN2014DN08299A (enExample)
MX (2) MX344635B (enExample)
PL (1) PL2827841T3 (enExample)
RU (1) RU2680959C2 (enExample)
WO (1) WO2013142374A1 (enExample)
ZA (1) ZA201407121B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
MX344635B (es) * 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
JP6335337B2 (ja) 2014-02-21 2018-05-30 アヴァディム・テクノロジーズ，インコーポレイテッド 尿道カテーテルの維持のための方法
AU2015288635B2 (en) * 2014-07-11 2018-07-26 Menicon Co., Ltd. Visibility-ensuring material, and device for discharging visibility-ensuring material
CA2958421C (en) * 2014-08-29 2023-10-17 Aarhus Universitet Positively charged co-polymers for use as antimicrobial agents
WO2016081724A2 (en) 2014-11-19 2016-05-26 Avadim Technologies, Inc. Method for the prevention and treatment of acne
CN110740744A (zh) * 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
GB201711555D0 (en) * 2017-07-18 2017-08-30 Kent Innovation & Entpr Antibacterial compounds
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3934753B1 (en) * 2019-03-04 2025-11-05 Capretto EHF. Microbial removal
CN109847090B (zh) * 2019-03-25 2021-08-31 深圳市康乐美科技有限公司 一种具有抗菌、柔软特性的卫生巾
CA3143518A1 (en) 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
WO2021207164A1 (en) * 2020-04-08 2021-10-14 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
CN112048084A (zh) * 2020-08-21 2020-12-08 浙江隆泰医疗科技股份有限公司 一种低温交联的聚乙烯醇复合抗菌肽材料的制备方法
WO2026060306A1 (en) * 2024-09-13 2026-03-19 Macro Biologics, Inc. Compositions and uses of locally applied synthetic cationic and hydrophobic amino acid block copolymers, for prevention and treatment of bacterial and fungal infections

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595040B2 (en) 1986-07-01 1990-03-22 Ici Australia Operations Proprietary Limited Cyclohexane-1, 3-dione herbicides
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000050006A2 (en) * 1999-02-26 2000-08-31 Chiron Corporation Microemulsions with adsorbed macromoelecules and microparticles
US20030138453A1 (en) * 2000-09-28 2003-07-24 O'hagan Derek Microparticles for delivery of heterologous nucleic acids
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
WO2003020797A1 (en) 2001-08-30 2003-03-13 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (ja) 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造法
CA2443472A1 (en) 2002-02-07 2003-08-14 Ophtecs Corporation Liquid formulation for contact lenses
DK1585548T3 (en) * 2002-12-09 2018-09-03 Abraxis Bioscience Llc COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
WO2005005436A2 (en) * 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
WO2005018701A1 (en) * 2003-08-25 2005-03-03 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
US7314857B2 (en) * 2003-08-25 2008-01-01 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
CA2550872C (en) * 2003-12-30 2016-05-03 Stig Bengmark Surface protection of exposed biological tissues
EP1722819B1 (en) 2004-03-12 2007-12-26 Intercell AG Method for solubilising peptide mixtures
DK1927597T3 (en) 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
KR20080023218A (ko) * 2005-06-06 2008-03-12 노보자임스 에이/에스 항균성을 가진 폴리펩티드 및 그것을 코딩하는폴리뉴클레오티드
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
US20070190110A1 (en) * 2006-02-10 2007-08-16 Pameijer Cornelis H Agents and devices for providing blood clotting functions to wounds
KR101475447B1 (ko) * 2006-12-01 2014-12-23 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법
JP2010531189A (ja) 2007-06-25 2010-09-24 リポペプチド・アクチエボラーグ 新しい医療用製品
US20090081249A1 (en) * 2007-08-27 2009-03-26 Massachusetts Institute Of Technology Bi-Functional Polymer-Attached Inhibitors of Influenza Virus
EP2272897B1 (en) 2008-03-10 2016-12-28 The University of Tokyo Copolymer including uncharged hydrophilic block and cationic polyamino acid block having lateral chain to which hydrophobic radical is partially introduced, and use of copolymer
US20110098344A1 (en) * 2008-06-19 2011-04-28 Nippon Shinyaku Co., Ltd. Drug carrier
GB0818074D0 (en) * 2008-10-02 2008-11-05 Lytix Biopharma As Treatment of biofilms
CN102256613B (zh) * 2008-10-20 2014-09-10 莫伊莱麦屈克斯公司 用于治疗或者预防粘连的多肽
CA2750340C (en) * 2009-01-23 2017-09-19 Kane Biotech Inc. Biofilm-removing antimicrobial compositions and uses thereof
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
DK2563916T3 (en) * 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
EP2608800B1 (en) * 2010-08-23 2017-01-18 The Regents of The University of California Compositions and uses of materials with high antimicrobial activity and low toxicity
CN103370087A (zh) * 2011-01-19 2013-10-23 目立康株式会社 隐形眼镜用液体制剂
US9781949B2 (en) 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
MX344635B (es) 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
DE102014101663A1 (de) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
EP3194422B1 (en) 2014-09-19 2020-04-29 Tensive Controls, Inc. Anti-microbial peptides
AU2015338969B2 (en) 2014-10-30 2020-08-27 Biomet Manufacturing, Llc Methods of preventing surgical site infections
JP2016113373A (ja) 2014-12-11 2016-06-23 エスポ化学株式会社 抗菌性、抗ウイルス性を有する水溶性組成物
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
WO2019169324A1 (en) * 2018-03-02 2019-09-06 January Therapeutics, Inc. Nanoparticle compositions

Similar Documents

Publication Publication Date Title
Dixon et al. Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing: D. Dixon, M. Edmonds
US12016898B2 (en) Compositions and uses of antimicrobial materials with tissue-compatible properties
Sarheed et al. Antimicrobial dressings for improving wound healing
Bertesteanu et al. Polymicrobial wound infections: pathophysiology and current therapeutic approaches
Rathna et al. Advancements in wound healing: integrating biomolecules, drug delivery carriers, and targeted therapeutics for enhanced tissue repair
KR20120022930A (ko) 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법
JP2020513016A5 (enExample)
US20240366717A1 (en) Antimicrobial matrix formed from peptide hydrogels
Karri et al. Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers
Abzaeva et al. Modern topical hemostatic agents and unique representatives of their new generation
Khan et al. Emerging Trend of Thiolated Polymers/materials and nanomedicine in wound healing
RU2019103612A (ru) Композиции и применение противомикробных материалов со свойствами биологической совместимости
Reddy Karri et al. Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers.
HK1206614B (en) Compositions and uses of antimicrobial materials with tissue-compatible properties